Concepedia

Amélien Sanlaville

AS

Statistics

Publications

5

Citations

1.2K

H-Index

5

Active since

2013

Affiliations

Inserm(Current)

Université Claude Bernard Lyon 1

Centre de Recherche en Cancérologie de Lyon

Centre National de la Recherche Scientifique

Centre Léon Bérard

Amélien Sanlaville is an author at Inserm specializing in immunology, oncology, and cancer immunology.

ORCID

Publications per year

2013–2021

5

Publications

5

TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

Sébastien Viel, Antoine Marçais, Fernando Guimarães et al. · Science Signaling · 2016 · 640 citations

, , +12

Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment

Isabelle Le Mercier, Dominique Poujol, Amélien Sanlaville et al. · Cancer Research · 2013 · 193 citations · Full text

, , +17

Regulatory T cells promote cancer immune-escape through integrin αvβ8-mediated TGF-β activation

Alexandra Lainé, Ossama Labiad, Héctor Hernández‐Vargas et al. · Nature Communications · 2021 · 165 citations · Full text

, , +17

Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution

Roxane M. Pommier, Amélien Sanlaville, Laurie Tonon et al. · Nature Communications · 2020 · 102 citations · Full text

, , +17

Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 <sup>+</sup> and CD8 <sup>+</sup> T‐cell protective responses to breast cancer

Raphaël Mattiuz, Carine Brousse, Marc Ambrosini et al. · Clinical & Translational Immunology · 2021 · 55 citations · Full text

, , +17

1–5 of 5